Pancreatic Cancer Research

ResearcherUniversity of PittsburghActive in the last 2 years

Callie A. Hlavin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0825-1782; OpenAlex author ID A5022672189. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Implications of an Isolated Positive Vascular Groove After Whipple for Pancreatic Adenocarcinoma: A Single Institution, Retrospective Analysis. Co-author DOI 10.1002/jso.70052↗
  2. Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy. Co-author DOI 10.1245/s10434-020-09446-x↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Amer H. Zureikat · 2 shared papers, 2021–2025 · strength 0.38
  2. Ibrahim Nassour · 2 shared papers, 2021–2025 · strength 0.38
  3. Alessandro Paniccia · 2 shared papers, 2021–2025 · strength 0.38
  4. Jiage Qian · 1 shared paper, 2025 · strength 0.25
  5. Sebastiaan Ceuppens · 1 shared paper, 2025 · strength 0.25
  6. Aatur Dilip Singhi · 1 shared paper, 2025 · strength 0.25
  7. Mohamed A. Adam · 1 shared paper, 2021 · strength 0.13
  8. Richard S. Hoehn · 1 shared paper, 2021 · strength 0.13
  9. David L. Bartlett · 1 shared paper, 2021 · strength 0.13
  10. Nathan Bahary · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.